KEWAUNEE SCIENTIFIC CORP /DE/FALSE000005552900000555292022-06-292022-06-29

Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 29, 2022
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its charter)
Delaware 0-5286 38-0715562
(State or other jurisdiction of
incorporation or organization)
 (Commission File
 (IRS Employer
Identification No.)
2700 West Front Street
Statesville, NC 28677
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (704873-7202
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $2.50 par value
KEQUThe Nasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition
On June 29, 2022, Kewaunee Scientific Corporation issued a press release announcing its financial results for the fourth quarter and fiscal year ended April 30, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: June 29, 2022 By/s/ Donald T. Gardner III
 Donald T. Gardner III
 Vice President, Finance
Chief Financial Officer

EX-99.1 2 pressreleasefy22q4.htm EX-99.1 Document


Kewaunee Scientific Reports
Results for Fiscal Year and Fourth Quarter

Exchange:    NASDAQ (KEQU)                Contact:    Donald T. Gardner III

STATESVILLE, N.C. June 29, 2022 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2022.

Fiscal Year 2022 Fourth Quarter Results:

Sales during the fourth quarter of fiscal year 2022 were $49,715,000, an increase of 28.4% compared to sales of $38,707,000 from the prior year fourth quarter. The increase in sales resulted from both higher volumes for the Domestic segment as well as the implementation of price increases in response to higher raw material input costs, which are now flowing through production at a higher rate. Pre-tax earnings for the quarter were $2,345,000 compared to a pre-tax loss of $950,000 for the prior year period. Net loss for the quarter was $362,000 compared to $2,975,000 for the prior year. Net loss for the current quarter was unfavorably impacted by additional income tax expense of $2,561,000 due to the increase in the valuation allowance, largely driven by the Sale-Leaseback transaction executed on March 24, 2022, as part of the Company's re-capitalization strategy that is further discussed below. EBITDA1 for the quarter was $2,969,000 compared to a loss of $302,000 for the prior year period. Diluted loss per share was $0.13, as compared to a diluted loss per share of $1.08 in the prior year fourth quarter.

Domestic Segment - Domestic sales for the quarter were $37,720,000, an increase of 39.0% from sales of $27,139,000 in the prior year period. Net earnings for the domestic segment were $2,380,000 compared to a net loss of $56,000 in the prior year period. Domestic segment EBITDA was $2,957,000 compared to a loss of $34,000 for the prior year period. The year-over-year increase in sales resulted from both strong demand across all end-use markets as well as increased revenue per unit from price increases implemented earlier in the year now flowing through production and billings.

International Segment - International sales for the quarter were $11,995,000, an increase of 3.7% from sales of $11,568,000 in the prior year period as activity across the international markets remained strong. Net income for the international segment was $1,020,000 compared to $961,000 in the prior year period. International segment EBITDA was $1,456,000 compared to $1,529,000 for the prior year period. During the fourth quarter, the ASEAN market contributed at its highest level of the year as COVID-19 restrictions in the region begin to be lifted and sales returned to more normalized levels.

Corporate Segment – Corporate segment pre-tax net loss was $3,762,000 for the quarter, as compared to $3,880,000 in the prior year period. Corporate segment EBITDA loss for the quarter
1 EBITDA is a non-GAAP financial measure. See the table below for a reconciliation of EBITDA and segment EBITDA to net earnings (loss), the most directly comparable GAAP measure.

PHONE 704-873-7202 ● FAX 704-873-1275

was $1,444,000, a favorable improvement of 19.6% from corporate segment EBITDA loss of $1,797,000 for the prior year period. The primary driver of the improved EBITDA was the favorable impact from pension accounting because of the recovery of the plan assets at previous fiscal year-end.

The Company’s order backlog was $173.9 million on April 30, 2022, increasing from $138.1 million on January 31, 2022, and $114.5 million on April 30, 2021. This is the highest order backlog in the Company's history.

"Kewaunee delivered strong financial results during the fourth quarter of fiscal year 2022, responding to accelerating demand as construction activity continued to recover from COVID-19 lows," said Thomas D. Hull III, Kewaunee's President, and Chief Executive Officer. "Demand in the international markets remains strong, with an increasing rate of activity being felt in the ASEAN and Middle East markets, complementing what continues to be a strong Indian market. Demand across the United States was especially strong in the fourth quarter, with all our major geographies being extremely active."

"Profitability improved domestically during the fourth quarter based on higher manufacturing volumes as we continue to restore production capacity that was reduced due to the COVID-19 pandemic. Further, actions taken during the year to align pricing on new orders with rapidly inflating raw material inputs substantially mitigated the cost/price mismatch that we experienced during the previous four quarters. I am proud of how our Kewaunee Associates continue to work to serve our customers, overcoming numerous headwinds due to a historically tight labor market as well as managing through persistent supply chain challenges."

"Kewaunee has posted a record high backlog for the third time in the past four quarters, demonstrating the confidence customers have in our ability to meet their requirements in a dynamic operating environment. Domestically, our order backlog increase has been driven by strength in the life science and higher education end-use markets within the United States. Our international teams continue to see customers investing in large infrastructure projects requiring laboratories in India, the Middle East, and Africa and were awarded multiple, multi-year projects during the year. The strength in our backlog positions the Company well for the next fiscal year as the majority of these orders will deliver over the next twelve to eighteen months."

Fiscal Year 2022 Full Year Results:

Sales during fiscal year 2022 were $168,872,000, an increase of 14.5% compared to sales of $147,469,000 from the prior year. Pre-tax loss for the fiscal year was $2,485,000 compared to a pre-tax loss of $2,617,000 for the prior year. The net loss for the fiscal year was $6,126,000, compared to a net loss of $3,672,000 for the prior year. Results for the full year were affected by the factors previously mentioned, as well as the $4,170,000 due to the increase in the valuation allowance, largely driven by the Sale-Leaseback transaction executed on March 24, 2022. EBITDA for the fiscal year was $394,000 compared to $171,000 for the prior fiscal year. Diluted loss per share was $2.20, as compared to a loss per share of $1.33 in the prior fiscal year.

Domestic Segment - Domestic sales for the fiscal year were $126,848,000, an increase of 14.2% from sales of $111,035,000 in the prior year. This increase was driven by year-over-year volume growth as well as the implementation of price increases on new orders in response to higher raw material input costs. Domestic segment net loss was $229,000 compared to net income of $921,000 in the prior fiscal year. Domestic segment EBITDA was $2,223,000 compared to $3,560,000 for the prior year. Profitability was negatively impacted during the year by increased COVID-19 related disruptions, a previously disclosed cyber-attack, ongoing supply chain issues, labor shortages, and significantly elevated costs due to inflation. As discussed in previous press releases, the Company experienced significantly higher raw material costs of $4,559,000 throughout the year which could not be passed along to customers due to the fixed nature of the Company's contracts.

International Segment - International sales for the fiscal year were $42,024,000, an increase of 15.3% from sales of $36,434,000 in the prior year with strong activity in India being the principal driver of growth during the fiscal year. International segment net income was $2,333,000 compared to $2,049,000 in the prior fiscal year. International segment EBITDA was $3,571,000 compared to $3,164,000 for the prior year.

Corporate Segment – Corporate segment pre-tax net loss was $8,230,000 for the fiscal year, as compared to $6,642,000 in the prior fiscal year. Corporate segment EBITDA loss for the fiscal year was $5,400,000, a favorable improvement of 17.6% from corporate segment EBITDA loss of $6,553,000 for the prior year. The primary driver of the improved EBITDA was the favorable impact of pension accounting because of the recovery of the plan assets at previous fiscal year-end, partially offset by expenses related to the Company's decision to exit certain markets, where the Company had historically sold products directly, and professional fees related to financing activities.

Total cash on hand on April 30, 2022 was $6,894,000, as compared to $5,731,000 on April 30, 2021. Working capital was $49,272,000, as compared to $26,276,000 on April 30, 2021. Short-term debt was $1,588,000 on April 30, 2022, as compared to $6,828,000 at April 30, 2021, and long-term debt was $29,704,000 on April 30, 2022 as compared to $112,000 at April 30, 2021. The Company’s debt-to-equity ratio on April 30, 2022 was 1.07-to-1, as compared to 0.39-to-1 at April 30, 2021.

"The past fiscal year was another challenging year for Kewaunee as the economy re-opened from COVID-19 shutdowns and the pace of activity rose," said Thomas D. Hull III, Kewaunee's President, and Chief Executive Officer. "Fiscal year 2022 presented what were probably the most challenging headwinds the Company has ever had to manage. We experienced rapid inflation across most of our cost categories that initially had to be absorbed by the Company due to the fixed nature of contracts we enter into with customers. At the same time, we faced a surge in demand and the inability to rapidly ramp production to pre-COVID-19 levels due to staffing shortages and supply chain disruptions."

"Our vision for Kewaunee is to be 'the global supplier of choice with customers in the laboratory furniture and infrastructure markets.' In pursuing this vision, we continued making progress on strategic initiatives throughout the year, positioning Kewaunee well for the future:

We announced the decision to stop selling direct in certain markets where the Company historically had due to the lack of sufficient dealer coverage in the territory. Through updated and expanded dealer agreements, Kewaunee has solidified its coverage in these territories, which will enable the Company to focus on its manufacturing operations as well as serving its channel partners with excellence. Direct projects remain in our backlog that we will be delivering over the course of fiscal year 2023. Once these projects complete, Kewaunee's domestic segment will be principally a manufacturer of laboratory and technical furniture products, with our channel partners handling product installation, buy-outs, and freight.
We completed a re-capitalization of the Company through a Sale-Leaseback transaction of the Company's three manufacturing facilities and corporate headquarters located in Statesville, North Carolina. This transaction will enable the Company to terminate its credit facility with Wells Fargo and to deploy capital within the Company's manufacturing operations to improve cost and productivity.
We made significant progress across our domestic manufacturing operations as a result of our lean and continuous improvement journey. This sets us up well to continue to deploy capital to modernize our metal manufacturing operations over the next two to three years, further improving our competitiveness and increasing our capacity.

We realized the benefits of the investments we have made in our international team over the past few years, and were awarded several significant projects across the India, Middle East, Africa, and ASEAN regions."

"While significant economic uncertainty exists as we conclude fiscal year 2022, from continued broad-based inflation to concern about a possible pending recession, I am optimistic about the future based on the progress we continue to make in improving the fundamental operating capabilities of the organization. I am proud of how our Associates continue to respond to the challenges presented, recognizing the importance of Kewaunee's role in 'encouraging new discovery… Worldwide.'"

EBITDA and Segment EBITDA Reconciliation

Quarter Ended April 30, 2021DomesticInternationalCorporateConsolidated
Net Earnings (Loss)$(56)$961 $(3,880)$(2,975)
Interest Expense— 77 79 
Interest Income— (62)(5)(67)
Income Taxes(572)560 1,991 1,979 
Depreciation and Amortization594 68 20 682 
EBITDA$(34)$1,529 $(1,797)$(302)
Quarter Ended April 30, 2022DomesticInternationalCorporateConsolidated
Net Earnings (Loss)$2,380 $1,020 $(3,762)$(362)
Interest Expense— 13 223 236 
Interest Income— (59)(196)(255)
Income Taxes— 419 2,254 2,673 
Depreciation and Amortization577 63 37 677 
EBITDA$2,957 $1,456 $(1,444)$2,969 
Fiscal Year to Date April 30, 2021DomesticInternationalCorporateConsolidated
Net Earnings (Loss)$921 $2,049 $(6,642)$(3,672)
Interest Expense— 385 389 
Interest Income— (216)(7)(223)
Income Taxes245 1,063 (318)990 
Depreciation and Amortization2,394 264 29 2,687 
EBITDA$3,560 $3,164 $(6,553)$171 
Fiscal Year to Date April 30, 2022DomesticInternationalCorporateConsolidated
Net Earnings (Loss)$(229)$2,333 $(8,230)$(6,126)
Interest Expense— 30 602 632 
Interest Income— (197)(202)(399)
Income Taxes50 1,129 2,339 3,518 
Depreciation and Amortization2,402 276 91 2,769 
EBITDA$2,223 $3,571 $(5,400)$394 

About Non-GAAP Measures

EBITDA and Segment EBITDA are calculated as net earnings (loss), less interest expense and interest income, income taxes, depreciation, and amortization. We believe EBITDA and Segment EBITDA allow management and investors to compare our performance to other companies on a consistent basis without regard to depreciation and amortization, which can vary significantly between companies depending upon many factors. EBITDA and Segment EBITDA are not calculations based upon generally accepted accounting principles, and the method for calculating EBITDA and Segment EBITDA can vary among companies. The amounts included in the EBITDA and Segment EBITDA calculations, however, are derived from amounts included in the historical statements of operations. EBITDA and Segment EBITDA should not be considered as

alternatives to net earnings (loss) or operating earnings (loss) as an indicator of the Company’s operating performance, or as an alternative to operating cash flows as a measure of liquidity.

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company’s products include steel, wood, and laminate casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin worksurfaces and sinks.

The Company’s corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. Kewaunee Scientific's website is located at http://www.kewaunee.com.

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: competitive and general economic conditions and the ongoing impact of the COVID-19 pandemic, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers’ required delivery schedules; risks related to fluctuations in the Company’s operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, natural disasters and other Force Majeure events; and the ultimate impact on the Company of the cyber attack suffered on November 5, 2021. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders’ interest. Many important factors that could cause such a difference are described under the caption “Risk Factors,” in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2022, which you should review carefully. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Kewaunee Scientific Corporation
Condensed Consolidated Statements of Operations
($ and shares in thousands, except per share amounts)

 Three Months Ended
April 30,
Twelve Months Ended
April 30,
Net sales$49,715 $38,707 $168,872 $147,469 
Cost of products sold40,388 32,644 144,652 123,476 
Gross profit9,327 6,063 24,220 23,993 
Operating expenses7,086 6,716 26,828 25,309 
Operating earnings (loss)2,241 (653)(2,608)(1,316)
Pension income (expense)89 (288)355 (1,153)
Other income, net251 70 400 241 
Interest expense(236)(79)(632)(389)
Earnings (loss) before income taxes2,345 (950)(2,485)(2,617)
Income tax expense2,673 1,979 3,518 990 
Net earnings (loss)(328)(2,929)(6,003)(3,607)
Less: Net earnings attributable to the non-controlling interest34 46 123 65 
Net earnings (loss) attributable to Kewaunee Scientific Corporation$(362)$(2,975)$(6,126)$(3,672)
Net (loss) earnings per share attributable to Kewaunee Scientific Corporation stockholders
Weighted average number of common shares outstanding
Basic2,790 2,763 2,786 2,760 
Diluted2,790 2,763 2,786 2,760 

Kewaunee Scientific Corporation
Condensed Consolidated Balance Sheets
($ in thousands)

April 30,
April 30,
Cash and cash equivalents$4,433 $5,206 
Restricted cash2,461 525 
Receivables, less allowances41,254 32,882 
Inventories23,796 16,517 
Income tax receivable 955 
Note Receivable13,457 — 
Prepaid expenses and other current assets6,164 4,372 
Total Current Assets91,565 60,457 
Net Property, Plant and Equipment15,121 15,982 
Right of use assets7,573 9,279 
Other assets4,514 3,666 
Total Assets$118,773 $89,384 
Liabilities and Stockholders' Equity
Short-term borrowings$1,588 $6,828 
Current portion of financing lease liability126 21 
Current portion of operating lease liabilities1,319 1,348 
Current portion of financing liability575  
Accounts payable27,316 16,780 
Other Current Liabilities11,369 9,204 
Total Current Liabilities42,293 34,181 
Long-term portion of financing lease liability228 91 
Long-term portion of operating lease liabilities6,179 7,860 
Long-term portion of financing liability28,775  
Other non-current liabilities5,118 5,765 
Total Liabilities82,593 47,897 
Kewaunee Scientific Corporation Equity35,694 41,241 
Non-controlling interest486 246 
Total Stockholders' Equity36,180 41,487 
Total Liabilities and Stockholders' Equity$118,773 $89,384 

EX-101.SCH 3 kequ-20220629.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 kequ-20220629_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 kequ-20220629_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image_0a.jpg begin 644 image_0a.jpg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htm IDEA: XBRL DOCUMENT v3.22.2
Jun. 29, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 29, 2022
Entity Incorporation, State or Country Code DE
Entity File Number 0-5286
Entity Tax Identification Number 38-0715562
Entity Address, Address Line One 2700 West Front Street
Entity Address, City or Town Statesville
Entity Address, State or Province NC
Entity Address, Postal Zip Code 28677
City Area Code 704
Local Phone Number 873-7202
Title of 12(b) Security Common Stock, $2.50 par value
Trading Symbol KEQU
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0000055529
XML 8 kequ-20220629_htm.xml IDEA: XBRL DOCUMENT 0000055529 2022-06-29 2022-06-29 KEWAUNEE SCIENTIFIC CORP /DE/ false 0000055529 8-K 2022-06-29 DE 0-5286 38-0715562 2700 West Front Street Statesville NC 28677 704 873-7202 Common Stock, $2.50 par value KEQU NASDAQ false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://kewaunee.com/role/Cover Cover Cover 1 false false All Reports Book All Reports kequ-20220629.htm kequ-20220629.xsd kequ-20220629_lab.xml kequ-20220629_pre.xml pressreleasefy22q4.htm http://xbrl.sec.gov/dei/2021 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kequ-20220629.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "kequ-20220629.htm" ] }, "labelLink": { "local": [ "kequ-20220629_lab.xml" ] }, "presentationLink": { "local": [ "kequ-20220629_pre.xml" ] }, "schema": { "local": [ "kequ-20220629.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "kequ", "nsuri": "http://kewaunee.com/20220629", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kequ-20220629.htm", "contextRef": "i017cca672b91487793cf00abf7b8e8f9_D20220629-20220629", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://kewaunee.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kequ-20220629.htm", "contextRef": "i017cca672b91487793cf00abf7b8e8f9_D20220629-20220629", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kewaunee.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0000055529-22-000009-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000055529-22-000009-xbrl.zip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